Anlon Healthcare
add_icon

Anlon Healthcare

14.23
-0.18
(-1.25%)
Market Cap
756.35 Cr
PE Ratio
22.53
Volume
10,68,884.00
Day High - Low
14.44 - 14.18
52W High-Low
17.28 - 9.08
ann
There are new updates from the company1 day ago
Viewcross
right
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
756.35 Cr
EPS
5.93
PE Ratio
22.53
PB Ratio
3.33
Book Value
4.33
EBITDA
46.14
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
25.51
Debt to Equity
1.46
Forecast For
Actual

Company News

View All News
Caret
positive
Anlon Healthcare reports 136% revenue surge to ₹87.62 crore in Q1FY27, driven by acquisitions. EBITDA margin moderates to 17% due to raw material costs and integration expenses.
positive
Anlon Healthcare Limited has executed share swap agreements to acquire up to 32.52% in Apiqo Organics and 43.33% in Bizotic Lifescience, valuing the combined deal at approximately ₹1,533 crore.
positive
Anlon Healthcare Eyes 30% Revenue Growth in 3 Years7 days ago
Anlon Healthcare expects 30% revenue growth over the next three years, driven by acquisitions, new product launches, and capacity expansion.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,944.00
#1 4,66,430.72
38.42
#1 61,673.90
12.69
#1 11,565
26.53
51.65
8,600.00
2,28,302.98
77.48
11,067.00
13.95
2,568
65.50
77.85
4,893.00
1,86,113.99
85.88
13,886.20
20.34
2,138
3.28
49.55
1,205.00
1,21,251.20
25.63
27,657.90
17.64
5,026
-34.90
70.55
1,463.00
1,18,187.77
35.19
29,044.60
2.24
3,870
-39.18
55.73
2,281.00
1,04,294.74
#1 18.76
29,038.90
#1 26.75
5,356
16.00
34.34
2,433.10
1,00,486.05
48.44
14,636.40
14.85
1,938
29.13
43.28
1,200.00
1,00,160.29
31.59
35,058.60
3.90
4,158
-69.10
49.25
1,850.00
99,873.47
92.17
6,867.80
22.01
890
#1 123.93
77.62
1,667.00
95,915.50
25.70
34,145.20
5.56
3,503
25.21
65.52

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
46.47 %
Net Income Growth
42.83 %
Cash Flow Change
-598.14 %
ROE
-44.45 %
ROCE
43.74 %
EBITDA Margin (Avg.)
-2.90 %

Quarterly Financial Results

Quarterly Financials
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
49
33
52
36
51
88
Expenses
32
27
39
23
36
72
EBITDA
17
6
14
13
15
16
Operating Profit %
35 %
19 %
26 %
35 %
30 %
18 %
Depreciation
1
0
0
0
0
1
Interest
1
1
1
2
1
1
Profit Before Tax
16
5
12
11
14
14
Tax
-1
2
3
6
3
5
Net Profit
17
4
9
5
11
8
EPS in ₹
5.15
0.89
1.75
1.13
2.33
0.16

Balance Sheet

Balance Sheet
2021
2022
2023
2024
2025
2026
Total Assets
71
85
112
128
181
317
Fixed Assets
29
27
26
27
23
40
Current Assets
40
58
86
101
159
260
Capital Work in Progress
0
0
0
0
0
0
Investments
0
2
4
1
1
76
Other Assets
43
56
82
100
158
0
Total Equity & Liabilities
71
85
112
128
181
317
Current Liabilities
31
29
44
50
60
101
Non Current Liabilities
38
55
61
57
41
7
Total Equity
2
2
7
21
80
210
Reserve & Surplus
-10
-10
-5
5
41
157
Share Capital
12
12
12
16
40
53

Cash Flow

Cash Flow
2021
2022
2023
2024
2025
Net Cash Flow
-2
1
-1
2
-1
Investing Activities
-3
-0
-0
-3
3
Operating Activities
-15
-2
-3
-3
-23
Financing Activities
16
3
2
8
19

Share Holding

% Holding
Oct 2024
Apr 2025
Jun 2025
Aug 2025
Sept 2025
Dec 2025
Mar 2026
Jun 2026
Promoter
70.26 %
70.26 %
52.68 %
70.26 %
52.68 %
52.68 %
52.68 %
52.68 %
FIIs
0.00 %
0.00 %
14.42 %
0.00 %
0.00 %
0.23 %
0.32 %
1.67 %
DIIs
0.00 %
0.00 %
4.35 %
0.00 %
2.83 %
4.49 %
4.60 %
1.22 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
14.64 %
0.00 %
20.73 %
23.58 %
24.38 %
26.19 %
Others
29.74 %
29.74 %
13.92 %
29.74 %
23.75 %
19.02 %
18.02 %
18.24 %
No of Share Holders
109
131
9,125
135
9,126
11,412
12,484
34,671

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
11 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
11 Nov 2025 13.91 14.25
09 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
09 Feb 2026 12.12 12.61
24 Apr 2026 BONUS Bonus
1:1
24 Apr 2026 12.16 14.38
06 Mar 2026 SPLIT Split
2:10
24 Apr 2026 11.11 11.11
29 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
29 May 2026 13.89 14.25
30 Jul 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
30 Jul 2026 15.01 15.89

Announcements

Announcement under Regulation 30 (LODR)-Earnings Call Transcript5 hrs ago
Board Meeting Intimation for Rescheduled/Postponement Of Meeting1 day ago
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements4 days ago
Closure of Trading Window5 days ago
Board Meeting Intimation for Approve Notice Of 13Th Annual General Meeting Of The Company5 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome6 days ago
Announcement under Regulation 30 (LODR)-Investor Presentation7 days ago
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 01, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 31, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 31, 2026
Financial Results For The Quarter Ended June 30 2026Jul 30, 2026
Board Meeting Outcome for Financial Results For The Quarter Ended June 30 2026Jul 30, 2026
Board Meeting Intimation for Declaration Of Financial Results For The Quarter Ended June 30 2026Jul 27, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 20, 2026
Announcement For Incorporation Of Subsidiary CompanyJul 11, 2026
Announcement Of Incorporated Of Subsidiary Company Of Anlon Healthcare LimitedJul 09, 2026
Disclosure Regarding Interview/Podcast Of Chairman & Managing Director With Sumit Mehrotra Former Senior Anchor @CnbcawaazJul 06, 2026
Disclosure Regarding Interview Of Chairman & Managing Director With Money TVJul 01, 2026
Board Meeting Outcome for Incorporation Of Subsidiaries Of Anlon Healthcare LimitedJul 01, 2026
Closure of Trading WindowJun 30, 2026
Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015 - Invitation For TV Interview On NDTV Profit.Jun 11, 2026
Intimation Regarding Media Interaction Of Chairman & Managing DirectorJun 09, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptJun 09, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJun 03, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationJun 03, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 30, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 30, 2026
Considered Approved And Taken On Record Audited Financial Results For The Quarter And Year Ended 31St March 2026May 29, 2026
Board Meeting Outcome for To Consider And Approve Financial Results For The Quarter And Year Ended March 31 2026May 29, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 28, 2026
Board Meeting Intimation for To Consider And Approve The Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Financial Year Ended March 31 2026 Along With The Auditors Report Thereon.May 23, 2026
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportMay 13, 2026
Updates On AcquisitionMay 08, 2026
Announcements Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Apr 27, 2026
Announcement under Regulation 30 (LODR)-AllotmentApr 27, 2026
Intimation Of New ISINApr 22, 2026
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsApr 16, 2026
Board Meeting Outcome for For Entered Into Share Purchase Agreement With Remember India Health Links Private LimitedApr 16, 2026
Announcement under Regulation 30 (LODR)-Credit RatingApr 15, 2026
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 15, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 10, 2026
Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of AssociationApr 09, 2026
Corporate Action-Board recommends Bonus IssueApr 09, 2026
Corporate Action-updates on Outcome of Sub division / Stock SplitApr 09, 2026
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportApr 08, 2026
Closure of Trading WindowMar 25, 2026
Announcement under Regulation 30 (LODR)-Updates on AcquisitionMar 20, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 18, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 12, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationMar 11, 2026

Technical Indicators

RSI(14)
Neutral
42.68
ATR(14)
Less Volatile
0.59
STOCH(9,6)
Neutral
23.10
STOCH RSI(14)
Neutral
22.06
MACD(12,26)
Bearish
-0.08
ADX(14)
Weak Trend
19.33
UO(9)
Bearish
49.03
ROC(12)
Downtrend And Accelerating
-4.00
WillR(14)
Neutral
-74.79